Ruane Cunniff & Goldfarb Boosted By $96.98 Million Its Wells Fargo Co New (WFC) Stake; Last Week Incyte (INCY) Analysts

February 20, 2018 - By Winifred Garcia

Among 24 analysts covering Incyte (NASDAQ:INCY), 20 have Buy rating, 0 Sell and 4 Hold. Therefore 83% are positive. Incyte had 78 analyst reports since August 6, 2015 according to SRatingsIntel. The stock has “Buy” rating by BMO Capital Markets on Monday, September 11. The rating was maintained by Oppenheimer on Monday, November 9 with “Outperform”. As per Tuesday, January 2, the company rating was upgraded by RBC Capital Markets. The company was initiated on Thursday, August 13 by Barclays Capital. The firm earned “Buy” rating on Wednesday, August 12 by Zacks. The firm has “Buy” rating by Argus Research given on Tuesday, August 18. The rating was maintained by Raymond James on Thursday, February 15 with “Buy”. The stock of Incyte Corporation (NASDAQ:INCY) earned “Overweight” rating by JP Morgan on Thursday, September 3. The rating was maintained by Argus Research with “Buy” on Monday, September 26. The rating was maintained by BMO Capital Markets on Monday, June 5 with “Buy”. See Incyte Corporation (NASDAQ:INCY) latest ratings:

15/02/2018 Broker: RBC Capital Markets Rating: Buy New Target: $115.0 Maintain
15/02/2018 Broker: BMO Capital Markets Rating: Buy New Target: $175.0 Maintain
15/02/2018 Broker: Raymond James Rating: Buy Maintain
02/01/2018 Broker: BMO Capital Markets Rating: Buy New Target: $172.0 Maintain
02/01/2018 Broker: RBC Capital Markets Old Rating: Sector Perform New Rating: Outperform Old Target: $136 Upgrade
13/12/2017 Broker: Deutsche Bank Rating: Hold New Target: $106 Initiates Coverage On
21/11/2017 Broker: RBC Capital Markets Rating: Hold New Target: $120.0 Maintain
31/10/2017 Broker: SunTrust Rating: Buy New Target: $155.0 Maintain
01/11/2017 Broker: BMO Capital Markets Rating: Outperform Old Target: $162 New Target: $166 Maintain
26/10/2017 Broker: BMO Capital Markets Rating: Outperform Old Target: $163 New Target: $163 Maintain

Ruane Cunniff & Goldfarb Inc increased Wells Fargo Co New (WFC) stake by 35.91% reported in 2017Q3 SEC filing. Ruane Cunniff & Goldfarb Inc acquired 1.76 million shares as Wells Fargo Co New (WFC)’s stock declined 8.66%. The Ruane Cunniff & Goldfarb Inc holds 6.67 million shares with $368.03M value, up from 4.91M last quarter. Wells Fargo Co New now has $294.28 billion valuation. The stock increased 0.35% or $0.21 during the last trading session, reaching $60.16. About 10.29 million shares traded. Wells Fargo & Company (NYSE:WFC) has risen 9.67% since February 20, 2017 and is uptrending. It has underperformed by 7.03% the S&P500.

Since November 17, 2017, it had 0 insider buys, and 1 insider sale for $292,234 activity. $292,234 worth of stock was sold by Codel Franklin R on Friday, November 17.

Ruane Cunniff & Goldfarb Inc decreased Union Pac Corp (NYSE:UNP) stake by 13,900 shares to 27,335 valued at $3.17 million in 2017Q3. It also reduced Procter And Gamble Co (NYSE:PG) stake by 10,335 shares and now owns 32,146 shares. Fastenal Co (NASDAQ:FAST) was reduced too.

Investors sentiment decreased to 0.73 in 2017 Q3. Its down 0.15, from 0.88 in 2017Q2. It worsened, as 92 investors sold WFC shares while 725 reduced holdings. 103 funds opened positions while 495 raised stakes. 3.65 billion shares or 0.40% less from 3.66 billion shares in 2017Q2 were reported. Aristotle Capital Management Limited Liability invested 0% of its portfolio in Wells Fargo & Company (NYSE:WFC). Bridges Inv Management stated it has 1.11% of its portfolio in Wells Fargo & Company (NYSE:WFC). 18,501 were reported by Kepos Capital Limited Partnership. Macquarie Grp Limited stated it has 0.1% of its portfolio in Wells Fargo & Company (NYSE:WFC). Alps Advsrs invested 0.01% of its portfolio in Wells Fargo & Company (NYSE:WFC). Grassi Inv Management invested in 124,742 shares. 18 were reported by Advantage Inc. Pineno Levin & Ford Asset Management Inc holds 0.19% or 7,426 shares. Inv Centers Of America holds 0.31% of its portfolio in Wells Fargo & Company (NYSE:WFC) for 76,126 shares. American Registered Advisor holds 0.87% or 31,268 shares in its portfolio. Baker Ellis Asset Mgmt Ltd Limited Liability Company holds 24,489 shares. Willis Invest Counsel reported 418,124 shares. Ferguson Wellman Capital Mngmt has invested 1.59% in Wells Fargo & Company (NYSE:WFC). Quinn Opportunity Lc accumulated 67,500 shares. 278,719 were accumulated by Ontario Teachers Pension Plan Board.

Among 39 analysts covering Wells Fargo & Company (NYSE:WFC), 15 have Buy rating, 8 Sell and 16 Hold. Therefore 38% are positive. Wells Fargo & Company had 131 analyst reports since July 29, 2015 according to SRatingsIntel. The stock of Wells Fargo & Company (NYSE:WFC) has “Hold” rating given on Friday, October 13 by BMO Capital Markets. RBC Capital Markets maintained Wells Fargo & Company (NYSE:WFC) on Wednesday, August 30 with “Buy” rating. The rating was upgraded by Citigroup to “Buy” on Thursday, January 7. The stock of Wells Fargo & Company (NYSE:WFC) has “Neutral” rating given on Monday, October 10 by UBS. The stock of Wells Fargo & Company (NYSE:WFC) has “Buy” rating given on Wednesday, July 29 by Guggenheim. JP Morgan upgraded Wells Fargo & Company (NYSE:WFC) on Friday, October 9 to “Overweight” rating. The stock of Wells Fargo & Company (NYSE:WFC) has “Outperform” rating given on Wednesday, April 12 by Evercore. BMO Capital Markets maintained the stock with “Sell” rating in Friday, July 14 report. The stock of Wells Fargo & Company (NYSE:WFC) has “Hold” rating given on Friday, September 15 by Jefferies. Evercore upgraded the stock to “Buy” rating in Tuesday, September 8 report.

Investors sentiment increased to 1.04 in Q3 2017. Its up 0.02, from 1.02 in 2017Q2. It improved, as 39 investors sold Incyte Corporation shares while 161 reduced holdings. 59 funds opened positions while 149 raised stakes. 188.97 million shares or 2.28% more from 184.77 million shares in 2017Q2 were reported. Piedmont Advsr Limited Co has 4,313 shares for 0.01% of their portfolio. Bancorp Of Montreal Can reported 93,378 shares. Arizona State Retirement Sys accumulated 62,424 shares. Mirae Asset Global Invests accumulated 0.03% or 15,563 shares. Kistler reported 0% of its portfolio in Incyte Corporation (NASDAQ:INCY). Toronto Dominion Bank & Trust stated it has 0.02% in Incyte Corporation (NASDAQ:INCY). Pinnacle Associates holds 2,111 shares. Brinker Capital holds 0.01% of its portfolio in Incyte Corporation (NASDAQ:INCY) for 1,792 shares. San Francisco Sentry Investment (Ca) invested in 4,138 shares. Los Angeles Capital Mngmt & Equity Incorporated owns 22,816 shares or 0.02% of their US portfolio. Virtu Financial holds 4,639 shares. Hanson Mcclain Inc holds 0.01% or 1,000 shares in its portfolio. Dynamic Capital accumulated 30,867 shares. Cambridge Invest Rech Advsr Inc accumulated 3,149 shares or 0% of the stock. Alabama-based Fjarde Ap has invested 0.09% in Incyte Corporation (NASDAQ:INCY).

Incyte Corporation focuses on the discovery, development, and commercialization of proprietary therapeutics in oncology in the United States and internationally. The company has market cap of $18.38 billion. It offers JAKAFI for the treatment of myelofibrosis and polycythemia vera cancers. It currently has negative earnings. The companyÂ’s clinical stage products include ruxolitinib cream that is in Phase II clinical trial for the treatment of alopecia areata and atopic dermatitis; and baricitinib, which is in Phase III clinical trial for treatment of rheumatoid arthritis.

Since August 29, 2017, it had 1 buying transaction, and 7 sales for $292,287 activity. 1,820 shares valued at $250,068 were sold by Siegel Eric H. on Friday, September 1. The insider Hoppenot Herve sold $8.42M. Stein Steven H sold $263,875 worth of stock or 2,111 shares. BAKER BROS. ADVISORS LP bought $13.20 million worth of stock. 20,000 shares were sold by SWAIN PAULA J, worth $2.80 million. 3,000 Incyte Corporation (NASDAQ:INCY) shares with value of $415,230 were sold by Trower Paul. Flannelly Barry P had sold 714 shares worth $88,715 on Wednesday, September 13.

The stock increased 0.94% or $0.81 during the last trading session, reaching $86.84. About 603,099 shares traded. Incyte Corporation (NASDAQ:INCY) has risen 72.84% since February 20, 2017 and is uptrending. It has outperformed by 56.14% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: